.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Mylan Pharms Inc Company Profile

« Back to Dashboard

Summary for Applicant: Mylan Pharms Inc

Patents:0
Tradenames:159
Ingredients:157
NDAs:188
Drug Master File Entries: (click here to view)230
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc
NIZATIDINE
nizatidine
CAPSULE;ORAL075934-001Jul 9, 2002DISCNNo<disabled><disabled>
Mylan Pharms Inc
MINOCYCLINE HYDROCHLORIDE
minocycline hydrochloride
TABLET, EXTENDED RELEASE;ORAL090911-003Jul 20, 2010RXNo<disabled><disabled>
Mylan Pharms Inc
MORPHINE SULFATE
morphine sulfate
TABLET, EXTENDED RELEASE;ORAL200824-004Oct 18, 2011RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc